NATCO Pharma Limited Share Price & Technical Analysis
NATCOPHARM · ₹1,173 (+0.28%)
Healthcare / Drug Manufacturers - Specialty & Generic
₹1,173
+0.28%
NATCO Pharma Limited, a pharmaceutical company, engages in the research and development, manufacturing, and marketing of finished dosage formulations, active pharmaceutical ingredients (APIs), and intermediates in India, the United States, and internationally. The company offers formulations in various therapeutic areas, including cancers of blood, liver, kidney, lung, brain, breast, and ovary; an…
Price chart
Seasonality
May has 3 positive and 2 negative years (last 5 years shown)
7% return in May, 3% avg return in past 3 year May month.
35% return in 2026, 14% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | -7% | 20% | 5% | 10% | 7% | – | – | – | – | – | – | – | 35% |
| 25 | -16% | -35% | 3% | 7% | 4% | 5% | 1% | -10% | -8% | 3% | 7% | 2% | -37% |
| 24 | 7% | 14% | -5% | 5% | -2% | 12% | 16% | 13% | -8% | -1% | -4% | 0% | 46% |
| 23 | -6% | 1% | 4% | 1% | 7% | 11% | 19% | 9% | -5% | -9% | -2% | 2% | 32% |
| 22 | 0% | -5% | -13% | 4% | -12% | -6% | 5% | -11% | -2% | -1% | -7% | 0% | -49% |
Monthly return % by calendar month · historical pattern, not a forecast
Weak · Strong · Uptrend
NATCO Pharma Limited, a pharmaceutical company, engages in the research and development, manufacturing, and marketing of finished dosage formulations, active pharmaceutical ingredients (APIs), and intermediates in India, the United States, and internationally. The company offers formulations in various therapeutic areas, including cancers of blood, liver, kidney, lung, brain, breast, and ovary; and APIs in various categories, such as oncology, central nervous system, pain management, and cardiovascular care. It also provides orthopedic products comprising bisphosphonates, which are oral and injectable drugs; and gastroenterology products consisting of novel drugs for chronic hepatitis-B and hepatitis-C, as well as contract manufacturing services. In addition, the company offers neurology, cardiology and diabetology products for the treatment of hypertension, stable angina, and CHF. Further, the company provides agro chemicals and biological pest management solutions for management of insects, diseases, and weeds across a range of crops. NATCO Pharma Limited was incorporated in 1981 and is headquartered in Hyderabad, India.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
₹211.69B
P/E ratio
13.59
52W high
₹1,227
52W low
₹789.0
Volume
2,43,550
Beta
0.26
Related stocks in Healthcare
Ngl Fine-chem Ltd.
₹2,260
Frequently asked questions
- What is NATCO Pharma Limited share price today?
- NATCO Pharma Limited (NATCOPHARM) last traded around ₹1,173 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does NATCOPHARM have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for NATCOPHARM. Download the app for real-time alerts.
- How can I analyze NATCO Pharma Limited stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.